Highlights from the American Chemical Society journal, ACS Chemical Biology, are now available on EurekAlert!. Below is a link to the April 2007 edition.
In the current issue we learn:
- That a known antifungal drug can also inhibit the formation of new blood vessels. Understanding how blood vessels form is an important aspect in wound healing and cancer treatment.
- How nanoparticles can help deliver short interfering RNAs to cells more effectively, which may aid in the development of clinical applications of these RNAs
- That more is better, at least in terms of antigens that activate B cells.
- About a new, specific way to add molecular tags, like fluorescent sensors, to antibodies.
- That there are several ways to inhibit protein kinase B, an important cell signaling molecule that is activated in many kinds of cancers.
- How small invertebrates like worms and flies can be used in high throughput screening
http://www.eurekalert.org/jrnls/acs/index.php?page=chemicalbiology.
Journalists can arrange access of any of the articles featured in ACS Chemical Biology by sending an e-mail to newsroom@acs.org or by contacting m_woods@acs.org.
ACS Chemical Biology is a monthly journal exploring cellular function from both chemical and biological perspectives. In addition to research papers and reviews, the journal also publishes Spotlights of current research in chemical biology, Profiles of experts in the field, and Points of View from leading scientists. The journal web site is updated weekly with new content, and it features a WIKI and Ask the Expert.
The American Chemical Society – the world’s largest scientific society – is a nonprofit organization chartered by the U.S. Congress and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
Journal
ACS Chemical Biology